Linda-Gail Bekker
#84,863
Most Influential Person Now
Zimbabwean physician & academic
Linda-Gail Bekker's AcademicInfluence.com Rankings
Linda-Gail Bekkerphilosophy Degrees
Philosophy
#4624
World Rank
#7212
Historical Rank
Logic
#2042
World Rank
#2939
Historical Rank
Download Badge
Philosophy
Linda-Gail Bekker's Degrees
- Masters Medicine University of Cape Town
- PhD Medicine University of Cape Town
Why Is Linda-Gail Bekker Influential?
(Suggest an Edit or Addition)According to Wikipedia, Linda-Gail Bekker MBChB, DTMH, DCH, FCP is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is also Director of the Desmund Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society .
Linda-Gail Bekker's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. (2010) (3668)
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. (2014) (970)
- Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men (2012) (797)
- Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. (2005) (584)
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm (2009) (579)
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. (2016) (470)
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa (2021) (456)
- Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design (2005) (410)
- Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism (2010) (400)
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control (2006) (388)
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination (2018) (362)
- Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity (2003) (355)
- Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa (2007) (352)
- Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. (2016) (321)
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa (2009) (319)
- Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. (2000) (312)
- Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. (2011) (310)
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study (2011) (301)
- T cell responses to SARS-CoV-2 spike cross-recognize Omicron (2022) (284)
- Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. (2007) (275)
- Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients (2003) (273)
- Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. (2007) (262)
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. (2011) (257)
- Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. (2006) (254)
- Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. (2006) (252)
- Fertility Intentions and Reproductive Health Care Needs of People Living with HIV in Cape Town, South Africa: Implications for Integrating Reproductive Health and HIV Care Services (2009) (243)
- Reimagining HIV service delivery: the role of differentiated care from prevention to suppression (2016) (218)
- Combination HIV prevention for female sex workers: what is the evidence? (2015) (217)
- Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort (2016) (215)
- Immunopathologic Effects of Tumor Necrosis Factor Alpha in Murine Mycobacterial Infection Are Dose Dependent (2000) (208)
- Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community (2012) (204)
- Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. (2009) (203)
- Adjunctive interferon-&ggr; immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial (2012) (201)
- An action agenda for HIV and sex workers (2015) (201)
- HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial (2019) (199)
- Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease (2009) (197)
- Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission (2018) (193)
- Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. (2011) (191)
- Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. (2006) (189)
- High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. (2008) (185)
- How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control (2005) (171)
- Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited (2007) (168)
- Comprehensive clinical care for men who have sex with men: an integrated approach (2012) (163)
- Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa (2010) (160)
- TNF-α Controls Intracellular Mycobacterial Growth by Both Inducible Nitric Oxide Synthase-Dependent and Inducible Nitric Oxide Synthase-Independent Pathways1 (2001) (158)
- Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa (2005) (154)
- Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: The results of two consecutive community surveys conducted in the Western Cape, South Africa (2013) (153)
- Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. (2010) (151)
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) (2011) (148)
- Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial (2014) (147)
- The global response and unmet actions for HIV and sex workers (2018) (140)
- Tuberculosis Vaccines and Prevention of Infection (2014) (140)
- Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (2009) (140)
- Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis (2010) (139)
- Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa (2011) (138)
- HIV Risk and Associations of HIV Infection among men who have sex with men in Peri-Urban Cape Town, South Africa (2011) (138)
- CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2006) (137)
- Social mixing patterns within a South African township community: implications for respiratory disease transmission and control. (2011) (137)
- Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. (2015) (136)
- Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. (1998) (136)
- Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. (2005) (133)
- The impact of gender and income on survival and retention in a South African antiretroviral therapy programme (2009) (132)
- Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. (2011) (130)
- Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females (2017) (128)
- HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery (2019) (128)
- Mental health and sexual risk behaviours in a South African township: a community-based cross-sectional study. (2006) (128)
- HIV/AIDS Care and Counselling - a Multidisciplinary Approach: Book Review (2005) (126)
- Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis (2014) (125)
- Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. (2012) (123)
- Induction of ER Stress in Macrophages of Tuberculosis Granulomas (2010) (121)
- Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study (2013) (121)
- Implementation and Operational Research: Community-Based Adherence Clubs for the Management of Stable Antiretroviral Therapy Patients in Cape Town, South Africa A Cohort Study (2016) (119)
- Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa (2012) (118)
- Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study (2014) (118)
- When to Initiate Highly Active Antiretroviral Therapy in Sub-Saharan Africa? A South African Cost-Effectiveness Study (2006) (117)
- Rethinking HIV prevention to prepare for oral PrEP implementation for young African women (2015) (116)
- Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors (2010) (116)
- Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review (2013) (115)
- Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents (2018) (115)
- Gender inequality and HIV transmission: a global analysis (2014) (113)
- Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa (2015) (113)
- Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy (2010) (112)
- Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status (2011) (110)
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. (2014) (109)
- The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis (2018) (109)
- Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment (2008) (108)
- Building our youth for the future (2015) (108)
- Identifying At-Risk Populations in Kenya and South Africa: HIV Incidence in Cohorts of Men Who Report Sex With Men, Sex Workers, and Youth (2012) (108)
- Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study (2015) (105)
- Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. (2010) (105)
- An Incentivized HIV Counseling and Testing Program Targeting Hard-to-Reach Unemployed Men in Cape Town, South Africa (2012) (104)
- High Acceptability of a Vaginal Ring Intended as a Microbicide Delivery Method for HIV Prevention in African Women (2012) (101)
- Linkage to HIV Care From a Mobile Testing Unit in South Africa by Different CD4 Count Strata (2011) (101)
- Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice (2002) (100)
- Preventing HIV Among Young People: Research Priorities for the Future (2013) (99)
- Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa (2016) (99)
- Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines (2004) (98)
- Men who have sex with men sensitivity training reduces homoprejudice and increases knowledge among Kenyan healthcare providers in coastal Kenya (2013) (98)
- Expanding the Space: Inclusion of Most-at-Risk Populations in HIV Prevention, Treatment, and Care Services (2011) (97)
- Guideline on safer conception in fertile HIV-infected individuals and couples. (2011) (97)
- Rates of HIV testing and diagnosis in South Africa: successes and challenges (2015) (97)
- The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. (2012) (96)
- Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework (2016) (96)
- Frailty in HIV-Infected Adults in South Africa (2013) (96)
- Organisational best practices towards gender equality in science and medicine (2019) (96)
- Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. (2015) (93)
- Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women (2016) (92)
- Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa (2013) (91)
- High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron (2021) (88)
- Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. (2006) (88)
- Tuberculosis control has failed in South Africa--time to reappraise strategy. (2011) (88)
- Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa (2016) (87)
- Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. (2017) (87)
- Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. (2008) (87)
- IAPAC Guidelines for Optimizing the HIV Care Continuum for Adults and Adolescents (2015) (87)
- The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study (2020) (86)
- From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward. (2021) (85)
- rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. (1997) (85)
- PrEP implementation research in Africa: what is new? (2016) (83)
- Vaginal Ring Adherence in Sub-Saharan Africa: Expulsion, Removal, and Perfect Use (2012) (83)
- The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents (2006) (82)
- HIV viraemia and mother‐to‐child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa (2017) (82)
- Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. (2010) (82)
- Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner (2021) (81)
- Behavioral and biomedical combination strategies for HIV prevention. (2012) (79)
- Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults (2021) (79)
- HIV / Aids Care and Counselling - a Multidisciplinary Approach, 3rd ed. A. van Dyk : book review (2005) (79)
- Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2016) (78)
- Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts (2014) (76)
- Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa (2007) (76)
- Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa (2013) (74)
- Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial (2018) (74)
- Clients’ perspectives on HIV/AIDS care and treatment and reproductive health services in South Africa (2008) (73)
- Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection (2016) (73)
- Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study (2012) (72)
- Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria (2012) (72)
- Antiretroviral therapy in a community clinic--early lessons from a pilot project. (2003) (71)
- Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study (2011) (71)
- Adolescent lives matter: preventing HIV in adolescents (2018) (70)
- Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study (2015) (69)
- Sexual risk behaviours and HIV-1 prevalence among urban men who have sex with men in Cape Town, South Africa. (2010) (69)
- Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. (2018) (69)
- Overcoming Biological, Behavioral, and Structural Vulnerabilities: New Directions in Research to Decrease HIV Transmission in Men Who Have Sex With Men (2013) (69)
- Expert consensus statement on the science of HIV in the context of criminal law (2018) (68)
- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. (2016) (66)
- Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis. (2005) (64)
- Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring. (2015) (64)
- Earlier HIV diagnosis--are mobile services the answer? (2010) (64)
- Translation and cross-cultural adaptation of a mental health battery in an African setting. (2006) (64)
- HIV and adolescents: focus on young key populations (2015) (64)
- Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. (2010) (64)
- Correction of Defective Host Response to Mycobacterium Bovis BCG Infection in TNF-Deficient Mice by Bone Marrow Transplantation (2000) (64)
- Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa (2013) (63)
- Global PrEP roll-out: recommendations for programmatic success. (2019) (63)
- Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. (2010) (63)
- Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. (2016) (63)
- Antiretroviral Therapy and TB Notification Rates in a High HIV Prevalence South African Community (2011) (62)
- Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. (2000) (62)
- Shared Air: A Renewed Focus on Ventilation for the Prevention of Tuberculosis Transmission (2014) (62)
- Acceptability and use of a dapivirine vaginal ring in a phase III trial. (2017) (62)
- Handbook of HIV Medicine (2008) (62)
- Tuberculosis in a South African prison - a transmission modelling analysis. (2011) (62)
- Brief report: methods for collecting sexual behaviour information from South African adolescents--a comparison of paper versus personal digital assistant questionnaires. (2007) (61)
- Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. (2012) (61)
- Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. (2009) (61)
- Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness (2014) (60)
- The Political, Research, Programmatic, and Social Responses to Adolescent Sexual and Reproductive Health and Rights in the 25 Years Since the International Conference on Population and Development. (2019) (60)
- A Qualitative Analysis of Factors Influencing HPV Vaccine Uptake in Soweto, South Africa among Adolescents and Their Caregivers (2013) (58)
- Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study (2014) (58)
- Adjunctive Thalidomide Therapy of Childhood Tuberculous Meningitis: Possible Anti-Inflammatory Role (2000) (57)
- High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa (2011) (57)
- Assessing Priorities for Combination HIV Prevention Research for Men Who have Sex with Men (MSM) in Africa (2013) (56)
- Human Rights Violations among Men Who Have Sex with Men in Southern Africa: Comparisons between Legal Contexts (2016) (56)
- Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings (2012) (55)
- Indoor Social Networks in a South African Township: Potential Contribution of Location to Tuberculosis Transmission (2012) (55)
- Is Obesity a Risk Factor for Vaccine Non-Responsiveness? (2013) (53)
- The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study (2015) (52)
- Predictors of HIV, HIV Risk Perception, and HIV Worry Among Adolescent Girls and Young Women in Lilongwe, Malawi (2017) (52)
- Childhood tuberculosis infection and disease: a spatial and temporal transmission analysis in a South African township. (2009) (52)
- Combination HIV Prevention among MSM in South Africa: Results from Agent-based Modeling (2014) (51)
- Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV (2018) (51)
- The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. (2010) (51)
- Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. (2006) (50)
- High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns (2018) (49)
- SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron (2021) (48)
- Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African township (2014) (48)
- Community Viral Load and CD4 Count Distribution Among People Living With HIV in a South African Township: Implications for Treatment as Prevention (2013) (48)
- Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study (2018) (47)
- Adolescents’ experience of a rapid HIV self-testing device in youth-friendly clinic settings in Cape Town South Africa: a cross-sectional community based usability study (2016) (47)
- Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? (2020) (47)
- Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission (2015) (46)
- Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. (2010) (45)
- Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa (2014) (45)
- Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. (2013) (44)
- Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. (2008) (44)
- Standard Measures are Inadequate to Monitor Pediatric Adherence in a Resource-Limited Setting (2010) (44)
- ‘Scared of going to the clinic’: Contextualising healthcare access for men who have sex with men, female sex workers and people who use drugs in two South African cities (2018) (44)
- Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine (2018) (43)
- PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial (2021) (43)
- Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa (2019) (42)
- Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT (2017) (41)
- Comparing Youth-Friendly Health Services to the Standard of Care Through “Girl Power-Malawi”: A Quasi-Experimental Cohort Study (2018) (40)
- Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV (2021) (39)
- Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir (2013) (39)
- HIV prevalence and risk among people who inject drugs in five South African cities. (2016) (39)
- A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus. (2010) (39)
- Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection (2015) (38)
- Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial (2020) (38)
- The Anticipated Clinical and Economic Effects of 909090 in South Africa (2016) (38)
- Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa (2019) (38)
- MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel (2016) (38)
- Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa (2014) (38)
- Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. (2008) (38)
- Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study. (2021) (38)
- Preliminary results from Hlanganani (Coming Together): A structured support group for HIV-infected adolescents piloted in Cape Town, South Africa (2014) (37)
- Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study (2018) (37)
- Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa (2022) (37)
- Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi (2020) (36)
- The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review (2017) (36)
- Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP (2018) (36)
- Stumbling Blocks at the Clinic: Experiences of Seeking HIV Treatment and Care in South Africa (2018) (35)
- Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program: Insights from South Africa (2014) (35)
- Renal impairment in HIV‐infected patients initiating tenofovir‐containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa (2015) (35)
- Outcomes of a community-based HIV-prevention pilot programme for township men who have sex with men in Cape Town, South Africa (2013) (34)
- Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy (2012) (34)
- Southern African guidelines for the safe use of pre-exposure prophylaxis in men who have sex with men who are at risk for HIV infection : guidelines (2012) (34)
- The complex challenges of HIV vaccine development require renewed and expanded global commitment (2019) (34)
- Implementation and Operational Research: Evolution of Antiretroviral Therapy Services for HIV-Infected Pregnant Women in Cape Town, South Africa (2015) (34)
- Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study (2020) (33)
- Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment (2020) (33)
- Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection (2019) (33)
- Ethical Issues in Adolescent HIV Research in Resource-Limited Countries (2014) (33)
- The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study (2016) (33)
- PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa (2019) (32)
- Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. (2011) (32)
- Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential (2019) (32)
- Design and Evaluation of a Drama-Based Intervention to Promote Voluntary Counseling and HIV Testing in a South African Community (2006) (32)
- The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study (2015) (32)
- Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men (2015) (32)
- Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. (2021) (32)
- Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study (2020) (31)
- Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection (2018) (31)
- Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa (2021) (31)
- Low acceptability of medical male circumcision as an HIV/AIDS prevention intervention within a South African community that practises traditional circumcision. (2012) (31)
- SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity (2022) (31)
- Outcomes of a nurse‐managed service for stable HIV‐positive patients in a large South African public sector antiretroviral therapy programme (2014) (31)
- PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa (2020) (30)
- Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. (2013) (30)
- The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will (2015) (30)
- Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study (2012) (30)
- Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya (2021) (29)
- Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis (2020) (29)
- Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol (2013) (29)
- High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women (2017) (29)
- Elements of Condom-Use Decision Making among South African Men Who Have Sex with Men (2014) (29)
- "It's inside my body and it's mine". (2017) (28)
- Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention (2015) (28)
- Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. (2020) (28)
- Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. (2013) (28)
- Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. (2012) (28)
- Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa (2015) (28)
- Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-Infected and HIV-Uninfected Adolescent Females in South Africa (2014) (28)
- Community health care workers in South Africa are at increased risk for tuberculosis. (2010) (28)
- We neglect primary HIV prevention at our peril. (2016) (27)
- Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system (2010) (27)
- Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa (2021) (27)
- Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018 (2018) (27)
- Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota (2020) (27)
- A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa (2020) (27)
- Youth-Specific Considerations in the Development of Preexposure Prophylaxis, Microbicide, and Vaccine Research Trials (2010) (26)
- Prospects for HIV control in South Africa: a model-based analysis (2016) (26)
- Extending dispensing intervals for stable patients on ART. (2013) (26)
- Emergence and phenotypic characterization of C.1.2, a globally detected lineage that rapidly accumulated mutations of concern (2021) (26)
- The emerging need for adolescent-focused HIV care in South Africa (2009) (26)
- Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial (2020) (26)
- The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth (2019) (26)
- Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa. (2013) (26)
- Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier. (2017) (26)
- Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa (2012) (26)
- Scaling up pre-exposure prophylaxis in sub-Saharan Africa (2019) (25)
- Retinal Nerve Fibre Layer Thickness and Contrast Sensitivity in HIV-Infected Individuals in South Africa: A Case-Control Study (2013) (25)
- Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women (2013) (25)
- A Conditional Economic Incentive Fails to Improve Linkage to Care and Antiretroviral Therapy Initiation Among HIV‐Positive Adults in Cape Town, South Africa (2018) (25)
- Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? (2013) (25)
- Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap (2016) (25)
- Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study (2022) (25)
- Epidemiology of HIV-1 Subtypes Among Men Who Have Sex With Men in Cape Town, South Africa (2014) (25)
- Willingness to participate in HIV vaccine research in a peri-urban South African community (2006) (25)
- Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy (2013) (25)
- South African healthcare provider perspectives on transitioning adolescents into adult HIV care. (2016) (25)
- Defining adolescence: priorities from a global health perspective. (2018) (24)
- Pre-exposure prophylaxis works—it's time to deliver (2015) (24)
- Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial (2020) (24)
- Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression (2013) (24)
- Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis (2017) (24)
- HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town (2019) (23)
- Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? (2011) (23)
- Pre-exposure prophylaxis for South African adolescents: What evidence? (2015) (23)
- High risk human papillomavirus persistence among HIV-infected young women in South Africa. (2015) (23)
- Prospects for HIV control in South Africa: a model-based analysis. (2016) (23)
- Comparing four service delivery models for adolescent girls and young women through the ‘Girl Power’ study: protocol for a multisite quasi-experimental cohort study (2017) (23)
- Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa. (2005) (22)
- Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines (2020) (22)
- Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. (2020) (22)
- Increased Ocular Lens Density in HIV-Infected Individuals With Low Nadir CD4 Counts in South Africa: Evidence of Accelerated Aging (2013) (22)
- Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa (2022) (22)
- Monitoring of antiretroviral therapy in low-resource settings (2008) (22)
- Dispelling myths about sex workers and HIV (2015) (21)
- Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosis. (1998) (21)
- The power of peers and community in the continuum of HIV care. (2020) (21)
- Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial. (2020) (21)
- Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa. (2019) (21)
- Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern (2022) (21)
- Sibanye Methods for Prevention Packages Program Project Protocol: Pilot Study of HIV Prevention Interventions for Men Who Have Sex With Men in South Africa (2014) (21)
- Blood safety--at what cost? (2006) (20)
- Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery (2018) (20)
- HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade (2020) (20)
- Perspectives of South African youth in the development of an implant for HIV prevention (2018) (20)
- What do South African adolescents want in a sexual health service? Evidence from the South African Studies on HIV in Adolescents (SASHA) project. (2018) (20)
- Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa. (2014) (20)
- HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town (2018) (20)
- Cost of a dedicated ART clinic. (2007) (20)
- Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells (2019) (19)
- Sexual health, HIV risk, and retention in an adolescent HIV-prevention trial preparatory cohort. (2011) (19)
- Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential A Modeling Study (2019) (19)
- Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa. (2011) (19)
- TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders. (2019) (19)
- Exploring repeat HIV testing among men who have sex with men in Cape Town and Port Elizabeth, South Africa (2015) (19)
- Fostering successful and sustainable collaborations to advance implementation science: the adolescent HIV prevention and treatment implementation science alliance (2020) (18)
- Serum Adenosine Deaminase and Total Immunoglobulin G Correlate with Markers of Immune Activation and Inversely with CD4 Counts in Asymptomatic, Treatment-Naive HIV Infection (2013) (18)
- Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa. (2007) (18)
- Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence (2021) (18)
- Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update (2015) (18)
- An open‐label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose) (2020) (18)
- Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa. (2008) (18)
- Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid (2017) (18)
- The case for viral load testing in adolescents in resource‐limited settings (2017) (18)
- A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa (2010) (18)
- The end of HIV: Still a very long way to go, but progress continues (2017) (17)
- Impact of ART on TB Case Fatality Stratified by CD4 Count for HIV-Positive TB Patients in Cape Town, South Africa (2009–2011) (2014) (17)
- Cost-Effectiveness of a Package of Interventions for Expedited Antiretroviral Therapy Initiation During Pregnancy in Cape Town, South Africa (2014) (17)
- Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant (2021) (17)
- Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence (2020) (17)
- Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials (2011) (17)
- Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants (2016) (17)
- South African HIV-1 vaccine candidates - the journey from the bench to clinical trials. (2012) (17)
- Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia (2016) (17)
- Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy (2011) (17)
- Pre-exposure prophylaxis in Southern Africa: feasible or not? (2015) (16)
- The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa (2021) (16)
- HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project (2020) (16)
- Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. (2019) (16)
- Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe (2019) (16)
- High Asymptomatic Carriage With the Omicron Variant in South Africa (2022) (16)
- Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076) (2019) (16)
- Sexual reproductive healthcare utilisation and HIV testing in an integrated adolescent youth centre clinic in Cape Town, South Africa (2018) (16)
- Healthcare retention and clinical outcomes among adolescents living with HIV after transition from pediatric to adult care: a systematic review (2020) (16)
- Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa (2017) (16)
- HIV/AIDS: a new South Africa takes responsibility. (2009) (16)
- Isoniazid preventive therapy for tuberculosis in South Africa: an assessment of the local evidence base. (2014) (16)
- Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage (2022) (16)
- Mobile sexual health services for adolescents: investigating the acceptability of youth-directed mobile clinic services in Cape Town, South Africa (2019) (16)
- The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol (2014) (16)
- Review of preventative HIV vaccine clinical trials in South Africa (2020) (15)
- Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk (2021) (15)
- Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa (2022) (15)
- COVID-19 research in Africa (2020) (15)
- Association of Adolescent- and Caregiver-Reported Antiretroviral Therapy Adherence with HIV Viral Load Among Perinatally-infected South African Adolescents (2018) (15)
- Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067 (2018) (15)
- Chapter 10 – Co-pathogenesis of tuberculosis and HIV (2009) (15)
- Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities (2021) (15)
- Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis (2015) (15)
- “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa (2018) (15)
- 'I had made the decision, and no one was going to stop me': Facilitators of PrEP adherence during pregnancy and postpartum in Cape Town, South Africa (2020) (15)
- Attitude shifts and knowledge gains: Evaluating men who have sex with men sensitisation training for healthcare workers in the Western Cape, South Africa (2017) (15)
- Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study (2017) (14)
- Hit me with your best shot: dolutegravir - a space in the next WHO guidelines? (2015) (14)
- Early persistence of HIV pre-exposure prophylaxis (PrEP) in African adolescent girls and young women (AGYW) from Kenya and South Africa (2018) (14)
- Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study including a randomised controlled trial (2020) (14)
- Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study including a randomised controlled trial (2020) (14)
- Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment (2018) (14)
- Hope for HIV control in southern Africa: The continued quest for a vaccine (2017) (14)
- Feasibility and acceptability of conducting HIV vaccine trials in adolescents in South Africa: Going beyond willingness to participate towards implementation. (2018) (14)
- Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers. (2019) (14)
- Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa (2020) (13)
- Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits (2020) (13)
- Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. (2012) (13)
- High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African Adolescents. (2013) (13)
- Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines (2020) (13)
- Cardiovascular risk factors among ART‐experienced people with HIV in South Africa (2019) (13)
- Assessing the Impact of a Small-Group Behavioral Intervention on Sexual Behaviors Among Adolescent Girls and Young Women in Lilongwe Malawi: A Quasi-Experimental Cohort Study (2019) (13)
- Undetectable=untransmittable (U=U) messaging increases uptake of HIV testing among men: Results from a pilot cluster randomized trial (2020) (13)
- Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa (2022) (13)
- The relationship between intimate partner violence and probable depression among adolescent girls and young women in Lilongwe, Malawi (2020) (13)
- Centring adolescent girls and young women in the HIV and COVID-19 responses (2020) (13)
- Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies (2017) (13)
- Involvement of African men and transgender women who have sex with men in HIV research: progress, but much more must be done (2020) (13)
- No one left behind: how are we doing in the roll-out of PrEP as part of combination HIV prevention? (2016) (12)
- A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa (2021) (12)
- Ocular parameters of biological ageing in HIV-infected individuals in South Africa: Relationship with chronological age and systemic biomarkers of ageing (2013) (12)
- “. . . I’ve Gone Through This My Own Self, So I Practice What I Preach . . . ” (2016) (12)
- Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa. (2020) (12)
- Awareness and Interest in Intrauterine Contraceptive Device Use among HIV-Positive Women in Cape Town, South Africa (2012) (12)
- Special Report on the State of HIV/AIDS in South Africa (2010) (12)
- The impact of self-selection based on HIV risk on the cost-effectiveness of pre-exposure prophylaxis in South Africa. (2020) (12)
- Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. (2005) (12)
- HIV/AIDS vaccination in adolescents would be efficient and practical when vaccine supplies are limited. (2007) (12)
- Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection (2019) (12)
- CD 4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2015) (12)
- Ensuring Children and Adolescents Are Not Left Behind (2018) (12)
- Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men (2017) (12)
- HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens (2020) (12)
- Factors affecting linkage to HIV care and ART initiation following referral for ART by a mobile health clinic in South Africa: evidence from a multimethod study (2019) (12)
- Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages (2022) (11)
- Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap. (2022) (11)
- “I had Made the Decision, and No One was Going to Stop Me” —Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa (2021) (11)
- Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020 (2020) (11)
- Microbial function and genital inflammation in young South African women at high risk of HIV infection (2020) (11)
- In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs? (2018) (11)
- Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV) (2021) (11)
- The International AIDS Society—Lancet Commission on the future of the HIV response and global health (2017) (11)
- Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study (2021) (11)
- Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women (2012) (11)
- Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa (2018) (11)
- An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town. (2016) (11)
- Early pre-exposure prophylaxis (PrEP) discontinuation among pregnant and postpartum women: Implications for maternal PrEP roll out in South Africa (2021) (10)
- A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophages. (2006) (10)
- Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service (2013) (10)
- Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials (2014) (10)
- Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses (2014) (10)
- A social network typology and sexual risk-taking among men who have sex with men in Cape Town and Port Elizabeth, South Africa (2016) (10)
- Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa (2014) (10)
- We still need to beat HIV (2017) (10)
- Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community. (2014) (9)
- Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery (2020) (9)
- Lessons from two SARS-CoV-2 waves in South Africa (2021) (9)
- Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings (2019) (9)
- Human Immunodeficiency Virus type 1 elite neutralizers (2009) (9)
- A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa (2020) (9)
- Comparing Provider and Client Preferences for HIV Prevention Services in South Africa among Men Who Have Sex with Men (2017) (9)
- Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women (2020) (9)
- HIV control in young key populations in Africa. (2019) (9)
- The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT (2020) (9)
- DNA vaccines join the fight against COVID-19 (2022) (9)
- Low prevalence of renal dysfunction in HIV‐infected pregnant women: implications for guidelines for the prevention of mother‐to‐child transmission of HIV (2013) (9)
- Things to think about (2004) (9)
- Healthcare provider knowledge and attitudes about pre-exposure prophylaxis (PrEP) in pregnancy in Cape Town, South Africa (2020) (9)
- Trajectories of PrEP Adherence Among Young Women Aged 16 to 25 in Cape Town, South Africa (2021) (9)
- Quality of induced sputum using a human-powered nebuliser in a mobile human immunodeficiency virus testing service in South Africa. (2011) (9)
- Sexual risk factors associated with volunteering for HIV vaccine research in South Africa (2006) (8)
- Orphaned by AIDS (2002) (8)
- Achieving the Optimal Vaginal State: Using Vaginal Products and Study Gels in Uganda, Zimbabwe, and South Africa (2017) (8)
- Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project (2020) (8)
- Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial (2021) (8)
- TB and HIV co-infection: When to start antiretroviral therapy (2011) (8)
- Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project (2021) (8)
- Undetectable = Untransmittable (U = U) Messaging Increases Uptake of HIV Testing Among Men: Results from a Pilot Cluster Randomized Trial (2021) (8)
- Adolescents and HIV Vaccine Trials (2005) (8)
- Effectiveness of the Ad26.Cov2.S Vaccine in Health Care Workers in South Africa (2021) (8)
- Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial (2021) (8)
- Relationship between the Oral and Vaginal Microbiota of South African Adolescents with High Prevalence of Bacterial Vaginosis (2020) (8)
- Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis (2017) (8)
- The utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in South Africa to guide mitigation strategies. (2020) (7)
- The impact of antiretroviral treatment programs on tuberculosis notification rates. (2011) (7)
- Incidental Findings of Bacterial Vaginosis and Other Infections in Papanicolaou Smears of HIV-infected and HIV-uninfected Adolescent Females in South Africa. (2014) (7)
- The Hannan Crusaid Treatment Centre – early beginnings and lessons learnt (2014) (7)
- GeneXpert TB 8: A point-of-care diagnostic pilot. (2014) (7)
- Community perspectives of South African adolescents’ experiences seeking treatment at local HIV clinics and how such clinics may influence engagement in the HIV treatment cascade: a qualitative study (2020) (7)
- Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities (2021) (7)
- Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. (2018) (7)
- CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2 (2014) (7)
- Realization of an AIDS-free generation: ensuring sustainable treatment for children. (2014) (7)
- HIV prevention: better choice for better coverage (2022) (7)
- Antiretroviral therapy in South Africa--can we do it? (2002) (7)
- Hair as a biological marker of daily oral pre-exposure prophylaxis (PrEP) adherence and tenofovir/emtricitabine (TFV/FTC) exposure in the global iPrEx study (2011) (7)
- Knowledge of HPV among HIV-Infected and HIV-Uninfected Adolescent Women in South Africa. (2015) (7)
- TB transmission is associated with prolonged stay in a low socio-economic, high burdened TB and HIV community in Cape Town, South Africa (2020) (7)
- The mass miniature chest radiography programme in Cape Town, South Africa, 1948 - 1994: The impact of active tuberculosis case finding. (2016) (7)
- A review of the atomoRapid HIV self-testing device: an acceptable and easy alternative to facilitate HIV testing (2019) (7)
- Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries (2017) (7)
- The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa—study protocol (2021) (7)
- Leveraging the advances in HIV for COVID-19 (2020) (7)
- Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project. (2019) (7)
- Using Observational Data to Inform HIV Policy Change for Children and Youth (2018) (7)
- Childbearing intentions among sexually active HIV-infected and HIV-uninfected female adolescents in South Africa. (2017) (6)
- Adherence to antiretroviral therapy--achievable in the South African context? (2001) (6)
- Social Determinants of HIV Among Men Who Have Sex with Men in Cape Town (2016) (6)
- Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages (2023) (6)
- O10.3 High curable STI prevalence and incidence among young african women initiating PrEP in HPTN 082 (2019) (6)
- ‘Why would you promote something that is less percent safer than a condom?’: Perspectives on partially effective HIV prevention technologies among key populations in South Africa (2018) (6)
- Community-based management of multidrug-resistant tuberculosis in South Africa. (2010) (6)
- Presence and Persistence of Putative Lytic and Temperate Bacteriophages in Vaginal Metagenomes from South African Adolescents (2021) (6)
- Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services? (2020) (6)
- Curable sexually transmitted infections among women with HIV in sub-Saharan Africa (2022) (6)
- Outcomes from a multimodal, at‐scale community‐based HIV counselling and testing programme in twelve high HIV burden districts in South Africa (2021) (6)
- Tuberculosis and Healthcare Workers in Underresourced Settings. (2016) (6)
- The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants (2014) (6)
- PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project (2022) (6)
- Factors Associated with HIV Discussion and Condom Use with Sexual Partners in an Underserved Community in South Africa (2016) (6)
- Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth (2021) (6)
- A systematic review of contraceptive continuation among women living with HIV. (2018) (6)
- Implementation Science for Eliminating HIV Among Adolescents in High-Burden African Countries: Findings and Lessons Learned from the Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA) (2023) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis (2020) (5)
- Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women (2021) (5)
- Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development. (2014) (5)
- Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial (2018) (5)
- The spectrum and prognosis of AIDS-defining illnesses in Cape Town (2005) (5)
- Perceptions matter: Narratives of contraceptive implant robbery in Cape Town, South Africa (2020) (5)
- Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron (2022) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events (2012) (5)
- Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa (2022) (5)
- Adolescent enrolment in HIV prevention trials (2012) (5)
- Identifying Adolescent Girls and Young Women at High Risk for HIV Acquisition: A Risk Assessment Tool From the Girl Power-Malawi Study (2020) (5)
- Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women (2021) (5)
- Is it time to change our HIV testing policy in health care facilities? (2006) (5)
- Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression (2022) (5)
- Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa (2017) (5)
- Cost-effectiveness of public health strategies for COVID-19 epidemic control 1 in South Africa (2020) (5)
- Reaching underserved South Africans with integrated chronic disease screening and mobile HIV counselling and testing: A retrospective, longitudinal study conducted in Cape Town (2021) (4)
- Vaginal microbiota varies by geographical location in South African women (2019) (4)
- HIV prevention : Experiences from a biomedical HIV prevention trial among men who have sex with men ( MSM ) in Cape Town , South Africa (2012) (4)
- Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression. (2020) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Incremental costs of integrated PrEP provision and effective use counselling in community‐based platforms for adolescent girls and young women in South Africa: an observational study (2022) (4)
- Microbial function and genital inflammation in young South African women at high risk of HIV infection (2020) (4)
- Diet, physical activity, and obesity among ART-experienced people with HIV in South Africa (2021) (4)
- “The Money, It’s OK but It’s not OK”: Patients’ and Providers’ Perceptions of the Acceptability of Cash Incentives for HIV Treatment Initiation in Cape Town, South Africa (2021) (4)
- The science of Durban, AIDS 2016 (2017) (4)
- Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence (2021) (4)
- Early antiretroviral therapy mortality in resource-limited settings: what can we do about it? (2007) (4)
- AIDS prevention in South Africa (2006) (4)
- Be legally wise: When is parental consent required for adolescents’ access to pre-exposure prophylaxis (PrEP)? (2020) (4)
- Challenges with oral pre-exposure Prophylaxis (PrEP) disclosure among adolescent girls and young women (AGYW) in Kenya and South Africa (2018) (4)
- Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention (2021) (4)
- Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa (2018) (4)
- PrEP re-initiation after interruption by adolescent girls and young women in Kenya and South Africa (2019) (3)
- Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial (2020) (3)
- Adolescent healthcare: I’m Lovin’ it (2020) (3)
- An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol (2021) (3)
- Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. (2019) (3)
- Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron (2022) (3)
- Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women (2022) (3)
- The natural history of HIV infection in Africa. (2006) (3)
- Protecting South Africa's children from HIV; giving them our best shot (2005) (3)
- Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. (2022) (3)
- Mental health outcomes of a pilot 2-arm randomized controlled trial of a HIV-prevention program for South African adolescent girls and young women and their female caregivers (2021) (3)
- Contraceptive implants and efavirenz-based ART: friend or foe? (2015) (3)
- Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection (2020) (3)
- Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk. (2022) (3)
- A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity (2021) (3)
- A COVID-19 conference at AIDS 2020: Virtual (2020) (3)
- Antiretroviral Treatment Cohort Analysis Using Time-Updated CD4 Counts: Assessment of Bias with Different Analytic Methods (2011) (3)
- Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis? (2009) (3)
- P167 Impact of COVID-19 on adolescent girls and young women in a community-based HIV PrEP programme in South Africa (2021) (3)
- Governance for health: the HIV response and general global health (2019) (3)
- Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study (2019) (3)
- Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials (2020) (3)
- Differences in the ability to predict and prepare for sexual activity between HIV-infected and HIV-uninfected young South African Women (2018) (3)
- Ad26.COV2.S breakthrough infections induce high titers of antibodies capable of neutralizing variants of concern (2021) (3)
- Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression. (2020) (3)
- Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial (2021) (3)
- Can cash help eliminate mother-to-child HIV transmission? (2016) (3)
- Acceptability and feasibility of leveraging community‐based HIV counselling and testing platforms for same‐day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa (2022) (3)
- Does antiretroviral therapy have a role to play in the control of tuberculosis in South Africa? (2001) (2)
- Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics. (2021) (2)
- Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. (2023) (2)
- Do we need a national antiretroviral treatment register? (2003) (2)
- The Role of Families in Adolescent and Young Adults’ PrEP Use (2021) (2)
- Something to offer (2002) (2)
- Impact of HIV on admissions and deaths in a tuberculosis hospital--recommendations for admission and discharge criteria. (2003) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- “You are not alone”: a qualitative study to explore barriers to ART initiation and implications for a proposed community-based youth treatment club among young adults newly diagnosed with HIV in South Africa (2020) (2)
- Does Type of Social Support Influence Medication Adherence Among South African Adolescents Living With HIV? A Quantitative Analysis of Pilot Data (2022) (2)
- The question of the question: impactful implementation science to address the HIV epidemic (2022) (2)
- The epidemiology and pathophysiology of HIV--as seen by a South African. (2002) (2)
- Deciding when to institute terminal palliative care for AIDS patients--an evidence-based approach. (2001) (2)
- Uptake and acceptability of medical male circumcision among young males in two culturally distinct settings in South Africa: A longitudinal, community-based study (the MACHO study). (2020) (2)
- Africa and AIDS: still much work to be done. (2021) (2)
- Response to: “Inclusion as Illusion: Erasing Transgender Women in Research with MSM” (2021) (2)
- The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa (2021) (2)
- High prevalence of HIV and low awareness of HIV infection among young MSM and transgender women in Cape Town and Port Elizabeth, South Africa (2016) (2)
- Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case–control study (2022) (2)
- Afri-Can Forum 2 (2016) (2)
- Khuluma: Using Participatory, Peer-Led and Digital Methods to Deliver Psychosocial Support to Young People Living With HIV in South Africa (2021) (2)
- Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans (2022) (2)
- P432 High prevalence and incidence of curable STIs among young women initiating PrEP in a township in south africa (2019) (2)
- Supplementary material : Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial (2011) (2)
- Interesting times : horizons (2001) (2)
- Reply to Pasqualotto (2008) (2)
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm (cid:1) † (2009) (2)
- Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa (2019) (2)
- Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017 (2020) (2)
- Factors influencing adolescent girls and young women’s uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study (2022) (2)
- Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076) (2021) (2)
- Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study (2022) (2)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- Antiretroviral treatment protocol Provincial Administration Western Cape (based on national treatment guidelines). Version 1. (2003) (1)
- Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges (2016) (1)
- Long-acting agents for HIV treatment and prevention (2022) (1)
- Metabolism of Long-Acting Rilpivirine Following Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076). (2020) (1)
- Closing the NIH Fogarty Center threatens US and global health (2017) (1)
- The Association between Intimate Partner Violence and Depression Symptoms in a Cohort of Adolescent Girls and Young Women in Lilongwe, Malawi (2017) (1)
- In defence of the vulnerable (2002) (1)
- Trials and tribulations (2006) (1)
- Are the effects of isoniazid preventive therapy and HAART additive in preventing of HIV-associated tuberculosis? (2013) (1)
- O169 High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV: a randomised study (2007) (1)
- PrEP: An Opportunity to Address Unmet Adolescent Health Needs (2019) (1)
- Rethinking the challenges of paediatric HIV diagnosis. (2020) (1)
- Qualitative Identification of Intervention Preferences to Support Men’s Engagement and Retention in TB Care in South Africa (2022) (1)
- The AIDS pandemic in the 2020s: community responses bring female underserved populations into sharper focus (2021) (1)
- Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2017) (1)
- Persistent, Asymptomatic Colonization with Candida is Associated with Elevated Frequencies of Highly Activated Cervical Th17-Like Cells and Related Cytokines in the Reproductive Tract of South African Adolescents (2022) (1)
- Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020 (2021) (1)
- HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021 (2021) (1)
- Sexual Risk among Pregnant Women at Risk of HIV Infection in Cape Town, South Africa: What Does Alcohol Have to Do with It? (2021) (1)
- Participatory Prototyping of a Tailored Undetectable Equals Untransmittable Message to Increase HIV Testing Among Men in Western Cape, South Africa. (2021) (1)
- Understanding Oral Prep Interest Among South African Adolescents: The Role of Perceived Parental Support and PrEP Stigma (2022) (1)
- Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa (2022) (1)
- Genome Sequences of Anelloviruses, a Genomovirus, Microviruses, Polyomaviruses, and an Unclassified Caudovirus Identified in Vaginal Secretions from South African Adolescents (2022) (1)
- Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis (2022) (1)
- Prevalence and Determinants of Vitamin D Deficiency in 1825 Cape Town Primary Schoolchildren: A Cross-Sectional Study (2022) (1)
- Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017). (2019) (1)
- Developing and validating the Multidimensional Sexual Identity Stigma Scale among men who have sex with men in South Africa. (2021) (1)
- Interventions addressing the adolescent HIV continuum of care in South Africa: a systematic review and modified Delphi analysis (2022) (1)
- Impact of SARS-CoV-2 exposure history on the T cell and IgG response (2022) (1)
- Track C Epidemiology and Prevention Science (2012) (1)
- Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice (2022) (1)
- Ethically acceptable consent approaches to adolescent research in South Africa (2022) (1)
- Protecting healthcare workers: A critical part of the COVID-19 response. (2020) (1)
- Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis (2021) (1)
- Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial (2022) (1)
- An epidemic uncurbed: tuberculosis in Cape Town, South Africa, 1910–2010 (2017) (1)
- HIV-1 viral control varies by viral subtype in a large cohort of African adults with incident HIV-1 infection. (2019) (1)
- Reply to Ouattara et al.: past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa. (2007) (1)
- Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges (2016) (1)
- High risk HPV persistence among HIV-infected young women in South Africa (2015) (1)
- AIDS prevention in South Africa : prevention (2006) (1)
- Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges (2016) (1)
- Expanding HIV Prevention Options for Women (2013) (1)
- Early Mortality Among Patients with HIV-Associated Tuberculosis in Africa : Implications for the Time to Initiation of Antiretroviral Treatment (2007) (0)
- Iconographies supplémentaires de l'article : Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial (2011) (0)
- Intimate partner violence and early PrEP adherence among adolescent girls and young women in Cape Town, South Africa: A longitudinal analysis (2018) (0)
- make up JUNE issue nicky (2005) (0)
- South Africa is my fantasy world (2001) (0)
- A multi‐country cross‐sectional study to assess predictors of daily versus on‐demand oral pre‐exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe (2022) (0)
- Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized Trial (2022) (0)
- Des Martin - a tribute (2007) (0)
- Non-ART trained health-care workers needed to prescribe PrEP in South Africa. (2022) (0)
- CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2 (2014) (0)
- Lessons for the HIV response from structural innovations catalysed by COVID-19 (2022) (0)
- ' s response to reviews Title : HIV Risk and Associations of HIV Infection among men who have sex with men in Peri-Urban Cape Town , South Africa (2011) (0)
- Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic (2013) (0)
- Building capacity to facilitate policy implementation: A short course in adolescent and youth health in South Africa (2022) (0)
- Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study (2023) (0)
- HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use (2021) (0)
- Can we involve adolescents in HIV vaccine trials - can we afford not to? (2005) (0)
- Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection (2023) (0)
- Author's manuscript (2014) (0)
- Comparing real-time adherence measurements to tenofovir blood concentrations in MSM and transwomen PrEP users in Cape Town, South Africa (2016) (0)
- Incidental findings of bacterial vaginosis and other infections in papanicolaou smears of human immunodeficiency virus (HIV)-infected and human immunodeficiency virus (HIV)-uninfected adolescent females in South Africa (2014) (0)
- Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are now and where (2020) (0)
- Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa. (2023) (0)
- The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub‐Saharan Africa: state of the science and research priorities (2022) (0)
- High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial (2023) (0)
- The HIV response and global health – Authors' reply (2019) (0)
- Social Determinants of HIV Among Men Who Have Sex with Men in Cape Town (2016) (0)
- Women of Worth: the impact of a cash plus intervention to enhance attendance and reduce sexual health risks for young women in Cape Town, South Africa (2022) (0)
- Serum Adenosine Deaminase and Total Immunoglobulin G Correlate with Markers of Immune Activation and Inversely with CD4 Counts in Asymptomatic, Treatment-Naive HIV Infection (2012) (0)
- Pre-exposure prophylaxis adherence with real-time adherence feedback and partner HIV self-testing: A pilot trial among postpartum women (2021) (0)
- Correction to: Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa (2022) (0)
- iPrevent: Engaging youth as long-acting HIV prevention product co-researchers in Cape Town, South Africa (2021) (0)
- Goals for Girls: Evaluation of school-based sexual and reproductive health education programmes amongst adolescent female learners (2020) (0)
- Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics. (2021) (0)
- Self-reported Benefits of Study Participation in HVTN 503, “Phambili”. (2014) (0)
- TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
- Steve Lawn (13 March 1966 - 23 September 2016) (2017) (0)
- ’ s response to reviews Title : The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa : a retrospective cohort study (2015) (0)
- Investigating the association between TB transmission and socio-economic risk factors in a high TB and HIV burdened community in Cape Town, South Africa (2017) (0)
- Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa (2023) (0)
- P367 Hormonal contraception and risk of STIs and bacterial vaginosis in south african adolescents: a randomized trial (2019) (0)
- Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study) (2023) (0)
- HIV counselling : counselling (2002) (0)
- Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa (2021) (0)
- Heterologous vaccination of BNT162b2 in Ad26. COV2.S-vaccinated healthcare workers elicits long-term humoral immune response (2022) (0)
- Preliminary effectiveness and implementation outcomes of the IMARA-South Africa sexual health intervention on adolescent girls and young women: A pilot randomized trial (2023) (0)
- South Africa in my fantasy world : horizons (2001) (0)
- “We Should Be Taught Self-Respect, Self-Confidence and Self-Love”: Youth Perspectives of Adult Influences on Their Sexuality and Relationships Among South African Adolescents Living With HIV (2022) (0)
- The essentials about tuberculosis—a South African perspective Mario C Raviglione (2010) (0)
- Multidimensional Sexual Identity Stigma Scale (2021) (0)
- Dapivirine Vaginal Ring for HIV Prevention in Women in South Africa (2022) (0)
- Interrogating the promise of long-acting HIV pre-exposure prophylaxis. (2022) (0)
- A pilot study to show that asymptomatic sexually transmitted infections alter the foreskin epithelial proteome (2022) (0)
- Children and young women in eastern and southern Africa are key to meeting 2030 HIV targets: time to accelerate action (2023) (0)
- SAMJ F ORUM 350 Handbook of HIV Medicine (2010) (0)
- HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens (2020) (0)
- Learning from mistakes - and triumphs : horizons (2001) (0)
- International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status. (2017) (0)
- Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067 (2022) (0)
- A cost analysis of a sports-based sexual health education programme for adolescent girls in South African schools (2022) (0)
- Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens (2022) (0)
- The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence (2021) (0)
- Reply to Yates et al (2014) (0)
- National antiretroviral treatment register - a necessity? (2003) (0)
- Point-of-Care CD 4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics : A Cost-Effectiveness Analysis (2015) (0)
- Looking back, looking forward (2005) (0)
- In memoriam: Professor David Cooper (1949 to 2018) (2018) (0)
- Erratum: Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice (2022) (0)
- Response to “Oral PrEP for young African women and men” (2016) (0)
- Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines (2020) (0)
- Learing from mistakes - and triumphs (2001) (0)
- Attracting, equipping and retaining young medical doctors in HIV vaccine science in South Africa (2015) (0)
- Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. (2023) (0)
- Progress in vaccine development for infectious diseases-a Keystone Symposia report. (2023) (0)
- HIV & Hepatitis in the Americas 28–30 April 2016, Mexico City, Mexico (2016) (0)
- Correction to: Microbial function and genital inflammation in young South African women at high risk of HIV infection (2022) (0)
- In memoriam: Professor James Gita Hakim (1954 to 2021) (2021) (0)
- Cervicovaginal Human Papillomavirus Genomes, Microbiota Composition and Cytokine Concentrations in South African Adolescents (2023) (0)
- Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa (2021) (0)
- Antiretroviral therapy, sexually transmitted infections and adverse pregnancy outcomes in South Africa. (2020) (0)
- High rates of bacterial vaginosis and Chlamydia in a low-income, high-population-density community in Cape Town (2017) (0)
- Crossing the Finish Line. (2017) (0)
- Stephen Lawn, 19662016. (2016) (0)
- Participatory prototyping of a tailored U=U (undetectable=untransmittable) message to increase HIV testing in men in Western Cape, South Africa (2021) (0)
- In memoriam: Gita Ramjee (2020) (0)
- A time of celebration (2003) (0)
- Adolescence: Vulnerabilities and Opportunities – A Global Look at HIV, TB and HPV (2014) (0)
- World AIDS Day reminds us to refocus on communities (2019) (0)
- Stephen Lawn, 1966-2016. (2016) (0)
- Intimate partner violence and contraception among adolescent girls and young women: A longitudinal analysis of the Girl Power-Malawi cohort. (2022) (0)
- Design and Evaluation of a Drama-Based Intervention to Promote Voluntary Counseling and HIV Testing in a (2006) (0)
- Women of worth (WOW) project (2020) (0)
- Adherence to Daily Oral Pre-Exposure Prophylaxis (PrEP) During Pregnancy and the Postpartum Period in South African Women: A Cohort Study (2022) (0)
- In memoriam: Mark Wainberg, PhD (1945–2017) (2017) (0)
- HIV vaccines: progress and promise (2021) (0)
- In this month’s Bulletin (2019) (0)
- Assessing the association of stigma and HIV service and prevention uptake among men who have sex with men and transgender women in South Africa. (2023) (0)
- Attribute preferences for long-acting Pre-exposure Prophylaxis (PrEP): Results of a discrete choice experiment with South African youth (2018) (0)
- O05.3 The combined contraceptive vaginal ring increases Th17-related cytokines in the genital tract: a randomized crossover trial (2019) (0)
- Anderson Efficacy in Men Who Have Sex with Men Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis (2012) (0)
- A terrific journey for which I have great gratitude (2022) (0)
- Tribute - Des Martin (2007) (0)
- TNF-[alpha] in host immunity to tuberculosis : in vivo and in vitro studies of protection and pathogenesis (2000) (0)
- Perspectives of South African health providers on the design of an HIV prevention implant: Learning from challenges with contraceptive implant rollout (2018) (0)
- A bizarre battle (2003) (0)
- HIV/TB : guest editorial (2011) (0)
- Theory-driven formative research to support development of a pre-exposure prophylaxis (PrEP) demand creation campaign among young women in a South-African township (2022) (0)
- What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa (2023) (0)
- Correction to: Microbial function and genital inflammation in young South African women at high risk of HIV infection (2022) (0)
- Past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa [letter] [reply] (2007) (0)
- Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection (2018) (0)
- Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe (2022) (0)
- Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women (2022) (0)
- The passing of an AIDS Activist: in memorium, Archbishop Desmond Mpilo Tutu (2022) (0)
- Qualitative Analysis Using Social Maps to Explore Young Women's Experiences With Social Support of their Oral PrEP Use in Kenya and South Africa (2022) (0)
- HIV-related stigma, disclosure and social support: experiences among young pregnant and postpartum women living with HIV in South Africa (2022) (0)
- “I know why I am taking this pill”: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa (2023) (0)
- Excessive weight gain following therapy for hyperthyroidism — a major problem (2003) (0)
- Focusing on the positive to stay negative: Oral pre-exposure prophylaxis (PrEP) uptake, HIV risk and vulnerability among South African young women (2018) (0)
- Metabolic disorders in the HAART era : conference report (2001) (0)
- Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression (2022) (0)
- Identifying Critical Attributes and Attribute-Levels for a Discrete Choice Experiment on Oral Pre-Exposure Prophylaxis (PrEP) Delivery Among Young People in Cape Town and Johannesburg, South Africa. (2020) (0)
- Engaging youth as long-acting HIV prevention product co-researchers in the iPrevent study in Cape Town, South Africa (2019) (0)
- HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials (2012) (0)
- A crack in the dam wall (2003) (0)
This paper list is powered by the following services:
Other Resources About Linda-Gail Bekker
What Schools Are Affiliated With Linda-Gail Bekker?
Linda-Gail Bekker is affiliated with the following schools:
